Samsung Bioepis Biosimilars Report Sees Lower Price Boosting Uptake
New Quarterly Report Offers Insights On US Biosimilar Pricing And Market Share
Samsung Bioepis has published the first in a planned series of reports on the US biosimilars market, including insights into pricing, uptake and market share for various biosimilars.
